Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

488 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 488 results

Post-approval studies (Phase 4)Study completedNCT03098121
What this trial is testing

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

Who this might be right for
Chronic Hepatitis C
Taoyuan General Hospital 40
Early research (Phase 1)Study completedNCT00630058
What this trial is testing

MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 20
Testing effectiveness (Phase 2)WithdrawnNCT00814606
What this trial is testing

A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C

Who this might be right for
Hepatitis CHepatitis C Virus
University of Chicago
Testing effectiveness (Phase 2)Study completedNCT00722358
What this trial is testing

A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 15
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Testing effectiveness (Phase 2)Study completedNCT02301936
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 10
Large-scale testing (Phase 3)UnknownNCT02646111
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With and Without Ribavirin in Protease-Inhibitors ("PI") Failures

Who this might be right for
Hepatitis C
Tel-Aviv Sourasky Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT01278134
What this trial is testing

RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 170
Testing effectiveness (Phase 2)Study completedNCT01170962
What this trial is testing

Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 512
Early research (Phase 1)Study completedNCT01371162
What this trial is testing

RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 42
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Not applicableStudy completedNCT00709059
What this trial is testing

Efficacy of PegIntron and Rebetol in Previously Untreated Patients With Chronic Hepatitis C Infected With HCV Genotype 1/4/5/6 (Study P04243)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 538
Testing effectiveness (Phase 2)Study completedNCT00944684
What this trial is testing

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Bern 32
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Testing effectiveness (Phase 2)Study completedNCT00790673
What this trial is testing

CF102 in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis C
Can-Fite BioPharma 32
Large-scale testing (Phase 3)Study completedNCT01667731
What this trial is testing

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 224
Large-scale testing (Phase 3)Study completedNCT00381953
What this trial is testing

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

Who this might be right for
Hepatitis C
Foundation for Liver Research 33
Testing effectiveness (Phase 2)Study completedNCT01072695
What this trial is testing

Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
HCV Infection
Gilead Sciences 46
Not applicableStudy completedNCT02803138
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 256
Next Page